Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Aug 17, 2021 4:33pm
107 Views
Post# 33718535

Todays House Positions

Todays House Positions
House Positions for C:ARCH from 20210817 to 20210817
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 40,500 72,166 1.782 0   40,500 -72,166
89 Raymond James 12,850 22,742 1.77 0   12,850 -22,742
79 CIBC 6,900 12,426 1.801 1,857 3,311 1.783 5,043 -9,115
2 RBC 5,175 9,163 1.771 2,700 4,889 1.811 2,475 -4,274
57 Interactive 200 356 1.78 0   200 -356
124 Questrade 151 275 1.821 0   151 -275
80 National Bank 208 366 1.76 150 267 1.78 58 -99
68 Leede 157 276 1.758 226 404 1.788 -69 128
14 ITG 10 18 1.80 1,000 1,800 1.80 -990 1,782
7 TD Sec 5,253 9,361 1.782 8,011 14,310 1.786 -2,758 4,949
19 Desjardins 0   4,935 8,850 1.793 -4,935 8,850
16 Paradigm 0   10,100 17,814 1.764 -10,100 17,814
85 Scotia 0   10,125 18,017 1.779 -10,125 18,017
9 BMO Nesbitt 0   11,500 20,674 1.798 -11,500 20,674
1 Anonymous 22,200 39,708 1.789 43,000 76,523 1.78 -20,800 36,815
TOTAL 93,604 166,857 1.783 93,604 166,859 1.783 0 2

<< Previous
Bullboard Posts
Next >>